
Nicola Crosetto. Photo: Stefan Zimmerman
Researchers at Karolinska Institutet have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in the scientific journal Nature Communications.
Since the onset of the pandemic, thousands of viral genomes have been sequenced to reconstruct the evolution and global spread of the coronavirus. This is important for the identification of particularly concerning variants that are more contagious, pathogenic, or resistant to the existing vaccines.
For global surveillance of the SARS-CoV-2 genome, it is crucial to sequence and analyse many samples in a cost-effective way. Therefore, researchers in the Bienko-Crosetto laboratory at Karolinska Institutet and Science for Life Laboratory (SciLifeLab) in Sweden have developed a new method, named COVseq, that can be used for surveillance of the viral genome on a massive scale at a low cost.
Adapted a previous method
First, many copies of the viral genome are created using so-called multiplex PCR (polymerase chain reaction). The samples are then labelled and pooled together in the same sequencing library, using a previous method developed in the Bienko-Crosetto laboratory and now adapted for SARS-CoV-2 analysis.
“By performing reactions in very small volumes and pooling together hundreds of samples into the same sequencing library, we can sequence potentially thousands of viral genomes per week at a cost of less than 15 dollars per sample,” says Ning Zhang, who previously worked as a postdoctoral researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet and is co-first author together with PhD students Michele Simonetti and Luuk Harbers active at the same department.
Comparative analyses of 29 SARS-CoV-2 positive samples revealed that COVseq had a similar ability as the standard method to identify small changes in the genome. Analyses of 245 additional samples showed that COVseq also had a high ability to detect emergent coronavirus variants of potential concern. The key advantage of COVseq over existing methods is cost-effectiveness.
Could be used by public health agencies
“Our inexpensive method could immediately be used for SARS-CoV-2 genomic surveillance by public health agencies and could also be easily adapted to other RNA viruses, such as influenza and dengue viruses,” says Nicola Crosetto, senior researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and last author of the paper.
Original Article: Low-cost method for finding new coronavirus variants
More from: Karolinska Institutet
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
SARS-CoV-2 variants
- No, vaccines are not makingvariants of Sars-CoV-2 worse
Still, the surges of ever more immune-evasive variants raise legitimate questions about whether vaccines and boosters are still protecting us from infection, or should only be recommended for their ...
- Pan-vaccine antigen strategy confers protection against cross-clade SARS-CoV-2 variants, including vaccine-resistant Omicron variants
Study: Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice. Image Credit: Billion Photos/Shutterstoc ...
- SARS-CoV-2 Delta and Omicron transmission within educational settings in relation to community-based outbreaks and mitigation measures
Researchers assessed whether school closures during COVID-19 outbreaks prevented viral transmission in Australia.
- Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5
A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel ...
- XAV-19, the anti-SARS-CoV-2 GH-pAb of XENOTHERA best-in-class against all variants including BQ. 1.1
XAV-19 exhibits a strong neutralization activity against all omicron variants, including BQ.1.1, the main variant of SARS-CoV-2 in circulation to date. In the meantime, all monoclonal antibodies today ...
Go deeper with Google Headlines on:
SARS-CoV-2 variants
[google_news title=”” keyword=” SARS-CoV-2 variants” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
SARS-CoV-2 genomic surveillance
- TAG-VE meets to review latest scientific evidence on circulating SARS-CoV-2 variants
The Technical Advisory Group on Virus Evolution (TAG-VE) meets regularly to review the latest scientific evidence on circulating SARS-CoV-2 variants and advises WHO on whether a change in public ...
- A genome-based comparison of SARS-CoV-2 XBB recombinant and its parental lineage
The most recently detected SARS-CoV-2 recombinant is termed XBB ... XBB needs continual genome-based epidemiological surveillance as well as clinical management of illness features due to its ...
- Centre On 'Alert Mode' After SARS-CoV-2 RNA Found In Sewage Samples From Delhi, Mumbai
Mandaviya further appealed to the people to wear masks, avoid crowded places and follow Covid appropriate behaviour.
- New Insights Into The Postfusion Structure Of SARS-CoV-2 Spike Protein
Animated clip of SARS-CoV-2 fusing with a host cell. To see the full video, click on the image. Covid-19 begins when the SARS-CoV-2 virus first encounters cells in the upper airway that express a ...
- Coinfection with flu, SARS-CoV-2 described in children
Using data from two Respiratory Virus Hospitalizations Surveillance Network platforms ... of laboratory-confirmed influenza virus and SARS-CoV-2 coinfections among patients aged younger than ...
Go deeper with Google Headlines on:
SARS-CoV-2 genomic surveillance
[google_news title=”” keyword=”SARS-CoV-2 genomic surveillance” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]